It’s Time for FAIR Drug Pricing

En español | Today, AARP endorsed new legislation that would hold drug companies more accountable for their pricing decisions. Thank you to Sens. Tammy Baldwin (D-Wis.) and John McCain (R-Ariz.) and Rep. Jan Schakowsky (D-Ill.) for introducing the bipartisan FAIR Drug Pricing Act of 2016 calling on drug companies to be more transparent in how they price their products. As evidenced by the recent uproar over the lifesaving allergy drug EpiPen, exorbitant prescription drug prices and price increases have been …

Soaring Prices Put Drugs out of Reach for Many Americans

Retail prices for more than 100 widely used specialty prescription drugs surged by nearly 11 percent in 2013, according to a new AARP Public Policy Institute (PPI) report issued today. The report found that the average annual cost of a specialty medication used to treat chronic diseases and conditions rose to more than $53,000 — greater than the U.S. median income and more than twice the $23,500 median income of people on Medicare. Specialty-prescription-drug prices are 18 times higher than …